You are here

  • Home
  • Archive
  • Volume 77, Issue 10
  • PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2− BC patients with residual disease after neoadjuvant chemotherapy: a cohort study

Article metrics

Article menu
Original research
PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2− BC patients with residual disease after neoadjuvant chemotherapy: a cohort study

 

Online download statistics by month:

Online download statistics by month: June 2023 to April 2025

AbstractFullPdf
Jun 202324523469
Jul 202323624089
Aug 2023969322
Sep 2023666518
Oct 2023858323
Nov 2023585921
Dec 2023676932
Jan 20241157542
Feb 2024454525
Mar 2024595652
Apr 2024524935
May 2024434228
Jun 2024726737
Jul 2024323121
Aug 2024383424
Sep 202417717647
Oct 202413312862
Nov 2024938752
Dec 2024858534
Jan 2025403828
Feb 2025747328
Mar 2025585330
Apr 2025424221
Total20111924840